Introduction Most software teams measure quality using something called test coverage, a percentage that shows how much of the codebase was touched during testing. The higher the number, the safer the ...

Personalis shares rose after the company received Medicare coverage for its NeXT Personal molecular residual disease test for surveillance of patients with Stage I to III non-small cell lung cancer.

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

TOKYO, Feb 2 (Reuters) - Japan's government said on Monday that it has successfully retrieved rare-earth-rich seabed mud for the first time from depths of around 6 km (4 miles) during a test mission.

Engineers in Silicon Valley have been raving about Anthropic’s AI coding tool, Claude Code, for months. But recently, the buzz feels as if it’s reached a fever pitch. Earlier this week, I sat down ...

Virginia hasn’t scored from the floor since the early flurry – nine straight missed shots. Still getting the open looks they were getting, just not getting them down. Louisville is 3-of-13 from the ...

eSpeaks’ Corey Noles talks with Rob Israch, President of Tipalti, about what it means to lead with Global-First Finance and how companies can build scalable, compliant operations in an increasingly ...

Abstract: Despite the central role of test suites in the software development process, there is surprisingly limited information on how code and tests co-evolve to exercise different parts of the ...

Want to share links on Facebook? It may soon come with a monthly cost. Credit: Brent Lewin/Bloomberg via Getty Images Are you a creator who shares links on Facebook? Be sure not to go over your ...

Anthropic has launched a beta integration that connects its fast-growing Claude Code programming agent directly into Slack, allowing software engineers to delegate coding tasks without leaving the ...

Is it three steps forward, one step back for blood tests? At the 18th Clinical Trials on Alzheimer’s Disease, held December 1–4 in San Diego, new data on the FDA-approved Fujirebio Lumipulse plasma ...